Omnicell, Inc.
NASDAQOmnicell heads into Q2 earnings season with a striking divergence: the stock gained 8% on the week, yet short sellers and options traders are the most defensive they have been all year. The options signal is the sharpest tension in the setup. The put/call ratio has surged to 1.50, nearly 2.5 standard deviations above its 20-day average of 0.47 — and that average itself was built on…
Snapshot as of 1 Jul 2026
Omnicell heads into Q2 earnings season with a striking divergence: the stock gained 8% on the week, yet short sellers and options traders are the most defensive they have been all year. The options signal is the…
Omnicell just delivered its strongest quarter in years — and the market wasted no time responding. Q1 adjusted EPS of $0.55 nearly doubled the $0.32 consensus estimate. Revenue of $309.9M beat the $304M forecast. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OMCL — free to start on ORTEX.
Sign up for free →Open OMCL on ORTEX